CDS Surveillance Has Positive Clinical Impact, Research Indicates | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

CDS Surveillance Has Positive Clinical Impact, Research Indicates

August 7, 2013
by Gabriel Perna
| Reprints

According to the Orem, Utah-based research and consulting firm, KLAS Research, most providers that are using clinical decision support (CDS) surveillance systems say the technology has had a moderate to significant impact on clinical outcomes.

In total, 79 percent of providers (140 were surveyed for the report) say that CDS surveillance systems have led to mostly positive clinical outcomes. "Providers make it clear that they feel that CDS surveillance is having a positive impact on how well they are able to care for their patients," Adam Cherrington, research director and report author from KLAS, said in a statement. "This report doesn't just answer the question of whether CDS surveillance is having an impact on clinical outcomes; it also reveals which vendors are the best positioned and most effective at helping providers."

In the report, KLAS looked at a number of vendors, including Allscripts,Caradigm, Carefusion, Cerner, Epic, Hospira, Perahealth, Siemens, Truven Health Pharmacy, and Wolters Kluwer. KLAS broke the vendors into categories of pharmacy-focused surveillance, enterprise-wide surveillance and EMR surveillance.

The Health IT Summits gather 250+ healthcare leaders in cities across the U.S. to present important new insights, collaborate on ideas, and to have a little fun - Find a Summit Near You!


/news-item/cds-surveillance-has-positive-clinical-impact-research-indicates

See more on

betebettipobetngsbahis bahis siteleringsbahis